Viral Production
Viral Production - Related Videos
08:35
Production and Titering of Recombinant Adeno-associated Viral Vectors
0 Views •
Cited by 149 •
2011
Recombinant adeno-associated virus (rAAVs) vectors are becoming increasingly valuable for in vivo studies in animals. We describe how rAAVs can be produced in the laboratory and how these vectors can be titered to give an accurate reading of the number of infectious particles produced.
08:32
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
0 Views •
Cited by 2 •
2014
We describe a protocol to measure the antiviral cytokine production in mice infected with a model herpesvirus, murine gamma herpesvirus 68 (γHV68) that is closely-related to human Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). Utilizing genetically modified mouse strains and mouse embryonic fibroblasts (MEFs), we assessed the antiviral cytokine production both in vivo and ex vivo. “Reconstituting” the expression of innate immune components in knockout embryonic...
02:57
Assessing Antiviral Cytokine Production in Response to Viral Infection
0 Views •
2026
Source: Zhang, J., et al. Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production. J. Vis. Exp. (2014)This video demonstrates the process of infecting murine fibroblast cells with herpesvirus and monitoring the resulting antiviral cytokine release and gene expression. It outlines key steps, including viral infection, media collection for cytokine quantification, and cell harvesting for gene expression analysis.
03:17
Preparation and Induction of Borrelia burgdorferi Cultures for Viral Particle Production
0 Views •
2025
Source: Eggers, C. H. Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi. J. Vis. Exp. (2022)This video demonstrates the preparation of a genetically modified Borrelia burgdorferi culture engineered with dormant bacteriophage DNA carrying an antibiotic resistance gene. Following antibiotic selection and incubation, a chemical inducer triggers DNA damage, leading to excision, replication, and assembly of new virions containing the resistance gene. After a...
13:45
Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
0 Views •
Cited by 84 •
2011
The Virochip is a pan-viral microarray designed to simultaneously detect all known viruses as well as novel viruses on the basis of conserved sequence homology. Here we demonstrate how to run a Virochip assay to analyze clinical samples for the presence of both known and unknown viruses.
FAQs
Permissive host cells provide the biological environment required for viral entry, genome replication, viral protein synthesis, particle assembly, and release or recovery. These stages are linked, so inadequate support at one point can reduce the amount or consistency of material obtained later. Understanding the sequence helps researchers interpret production outcomes and connect them with viral biology.
Cellular conditions influence whether infection proceeds efficiently and whether newly formed particles can be recovered consistently. The cells must remain susceptible and permissive enough to support the relevant replication and assembly steps. Maintaining suitable conditions therefore affects both yield and reproducibility, which is especially important when preparations are compared across experiments or used in downstream immunology and infection studies.
Variation can arise from differences in the permissiveness of host cells, the progression of replication and assembly, or the efficiency of particle release and recovery. Inconsistent handling of these stages may change the resulting preparation and complicate experimental interpretation. Standardization and quality assessment address this problem by helping distinguish biological effects from production-related differences.
A high-level workflow begins by providing susceptible host cells with the conditions needed for infection, followed by viral genome replication and synthesis of viral proteins. New particles then assemble within the culture system and are released or recovered for further use. The resulting preparation is assessed for consistency before supporting research, diagnostic, therapeutic, or vaccine-related activities.
Quality assessment helps determine whether a viral preparation is sufficiently consistent for its intended experiment or application. By identifying unwanted variability after recovery, researchers can improve comparability between preparations and interpret immune or infection-related results with greater confidence. This step is particularly valuable when the material will support standardized experimental models or development efforts.
Produced virus can support research on host-pathogen interactions, immune recognition, pathogenesis, and antiviral responses. It also contributes to diagnostic, therapeutic, and vaccine-related work by providing material for controlled investigation. The appropriate use depends on the scientific question, while standardized preparation helps ensure that observed outcomes reflect the biology under study rather than inconsistent input material.
In this field, controlled viral preparations provide a basis for examining how hosts detect infection, respond to viral components, and develop antiviral defenses. They also enable researchers to study disease-related mechanisms and interactions between pathogens and host systems. Reproducible production is essential because differences in the preparation could otherwise obscure immune recognition or pathogenesis findings.